Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | David Simpson | Nov 11, 2021 | |||||||
GSM3935839 |
LK2DG1: LKR10_2D_shGFP_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935840 |
LK2DG2: LKR10_2D_shGFP_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935841 |
LK2DG3: LKR10_2D_shGFP_Rep3
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935842 |
LK2DG4: LKR10_2D_shGFP_Rep4
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935843 |
LK2DA1: LKR10_2D_shAnkrd35_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935844 |
LK2DA2: LKR10_2D_shAnkrd35_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935845 |
LK2DA3: LKR10_2D_shAnkrd35_Rep3
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935846 |
LK2DA4: LKR10_2D_shAnkrd35_Rep4
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935847 |
LKMEG1: LKR10_3D_shGFP_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935848 |
LKMEG2: LKR10_3D_shGFP_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935849 |
LKMEG3: LKR10_3D_shGFP_Rep3
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935850 |
LKMEG4: LKR10_3D_shGFP_Rep4
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935851 |
LKMEA1: LKR10_3D_shAnkrd35_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935852 |
LKMEA2: LKR10_3D_shAnkrd35_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935853 |
LKMEA3: LKR10_3D_shAnkrd35_Rep3
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3935854 |
LKMEA4: LKR10_3D_shAnkrd35_Rep4
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3938762 |
Tumor Cells: Untreated_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3938763 |
Tumor Cells: Untreated_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3938764 |
Tumor Cells: Cisplatin_Rep1
|
SRA | 1 | David Simpson | Nov 11, 2021 | ||||
GSM3938765 |
Tumor Cells: Cisplatin_Rep2
|
SRA | 1 | David Simpson | Nov 11, 2021 |